Nurse-led monitoring improves cancer-related fatigue

January 4, 2013
Nurse-led monitoring improves cancer-related fatigue
For patients with advanced cancer, nurse-led monitoring and optimized treatment of physical symptoms significantly improves cancer-related fatigue, according to research published online Jan. 2 in the Journal of Clinical Oncology.

(HealthDay)—For patients with advanced cancer, nurse-led monitoring and optimized treatment of physical symptoms significantly improves cancer-related fatigue, according to research published online Jan. 2 in the Journal of Clinical Oncology.

To examine the impact of optimizing treatment of accompanying symptoms on cancer-related , Pleun J. de Raaf, M.D., of the Erasmus MC Daniel den Hoed Cancer Center in Rotterdam, Netherlands, and colleagues conducted a trial involving 152 fatigued patients with advanced cancer. Patients were randomized in a 1:1 ratio to receive nurse-led monitoring and protocolized patient-tailored treatment of symptoms or usual care.

The researchers found that, over time, there was a significant improvement in general fatigue in favor of protocolized patient-tailored treatment, with significant differences compared with controls at months one and two. Specific secondary outcomes, including reduced activity and reduced motivation fatigue dimensions, fatigue numerical rating scale score, symptom burden, interference of fatigue with daily life, and anxiety, were also significantly better with patient-tailored treatment.

"It is advisable to refer fatigued patients with advanced cancer to a nurse trained in for monitoring symptom intensity, educating the patient, and referring to other , if necessary," the authors write. "Further research should focus on elucidating which components are responsible for the effect of improving symptom burden on fatigue and on establishing the cost-effectiveness of this intervention."

Explore further: L-carnitine does not reduce cancer-related fatigue

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

L-carnitine does not reduce cancer-related fatigue

September 18, 2012
(HealthDay)—Patients with invasive malignancies who take L-carnitine supplements do not experience a reduction in fatigue, pain, or depression, according to research published online Sept. 17 in the Journal of Clinical ...

Follow-up study finds prolonged fatigue for those who had chemotherapy for breast cancer

December 5, 2011
In a follow-up study, researchers at Moffitt Cancer Center and colleagues have found that patients who receive chemotherapy for breast cancer might experience prolonged fatigue years after their therapy. The new study, published ...

Web-Based program helps manage cancer-Related fatigue

March 13, 2012
(HealthDay) -- An Internet-based educational program helps disease-free cancer survivors better manage their cancer-related fatigue (CRF), according to research published online March 12 in the Journal of Clinical Oncology.

Ginseng fights fatigue in cancer patients, study finds

June 4, 2012
High doses of the herb American ginseng (Panax quinquefolius) over two months reduced cancer-related fatigue in patients more effectively than a placebo, a Mayo Clinic-led study found. Sixty percent of patients studied had ...

Cancer patients may not be getting adequate care for debilitating fatigue, study finds

December 18, 2012
(Medical Xpress)—Many people who have been through cancer and its treatment have trouble with their recovery because of severe, debilitating fatigue that can last for months or even years. But even though a variety of treatments ...

Recommended for you

New approach attacks 'undruggable' cancers from the outside in

January 23, 2018
Cancer researchers have made great strides in developing targeted therapies that treat the specific genetic mutations underlying a patient's cancer. However, many of the most common cancer-causing genes are so central to ...

Study: Cells of three advanced cancers die with drug-like compounds that reverse chemo failure

January 23, 2018
Researchers at Southern Methodist University have discovered three drug-like compounds that successfully reverse chemotherapy failure in three of the most commonly aggressive cancers—ovarian, prostate and breast.

'Hijacker' drives cancer in some patients with high-risk neuroblastoma

January 23, 2018
Researchers have identified mechanisms that drive about 10 percent of high-risk neuroblastoma cases and have used a new approach to show how the cancer genome "hijacks" DNA that regulates other genes. The resulting insights ...

Enzyme inhibitor combined with chemotherapy delays glioblastoma growth

January 23, 2018
In animal experiments, a human-derived glioblastoma significantly regressed when treated with the combination of an experimental enzyme inhibitor and the standard glioblastoma chemotherapy drug, temozolomide.

Researchers identify a protein that keeps metastatic breast cancer cells dormant

January 23, 2018
A study headed by ICREA researcher Roger Gomis at the Institute for Research in Biomedicine (IRB Barcelona) has identified the genes involved in the latent asymptomatic state of breast cancer metastases. The work sheds light ...

Boosting cancer therapy with cross-dressed immune cells

January 22, 2018
Researchers at EPFL have created artificial molecules that can help the immune system to recognize and attack cancer tumors. The study is published in Nature Methods.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.